Unbiased AI-powered news
5 stories related to this topic, newest first.
freepressjournal.inA study of T cells from patients with lupus nephritis found these cells are activated by local cytokines and may contribute to kidney injury. Some T cells showed reactivity to Epstein-Barr virus and cytomegalovirus.
nypost.comThe Independent reported that Bryan Johnson has been diagnosed with autoimmune gastritis. He attributes the condition to his former diet and plans extensive monitoring and new treatments.
theconstructionindex.co.ukThe Cambridge-based company released Phase 1 results showing remissions in rheumatoid arthritis and lupus patients. Plans for Phase 2a expansion and additional trials were also outlined.
manilatimes.netCullinan Therapeutics reported initial clinical results from two Phase 1 trials of CLN-978, a CD19xCD3 T cell engager, in patients with systemic lupus erythematosus and rheumatoid arthritis. The data were presented June 6 at the European Alliance of Associations for Rheumatology…
rte.ieThe biotechnology company, formerly known as Myeloid Therapeutics, secured the funding from Newpath Partners, ARCH Venture Partners and Hatteras Venture Partners. CREATE Medicines, cofounded by Siddhartha Mukherjee, is developing CAR-T therapies using myeloid cells to target soli…